{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:47:32Z","timestamp":1785869252629,"version":"3.56.0"},"reference-count":46,"publisher":"American Association for Cancer Research (AACR)","issue":"8","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA227984"],"award-info":[{"award-number":["R37CA227984"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016193","name":"University of Colorado School of Medicine, Anschutz Medical Campus","doi-asserted-by":"publisher","award":["Thoracic research initiative pilot funding"],"award-info":[{"award-number":["Thoracic research initiative pilot funding"]}],"id":[{"id":"10.13039\/100016193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA046934"],"award-info":[{"award-number":["P30CA046934"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["NIH S10 OD027023"],"award-info":[{"award-number":["NIH S10 OD027023"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The central nervous system (CNS) is a common site of metastasis for both non\u2013small cell and small cell lung cancer, yet the therapeutic strategies to prevent and decrease lung cancer brain metastases (BM) remain limited. Tyrosine kinase inhibitors have shown promising results in increasing overall response in BM, owing to their brain penetrance and increased effectiveness; however, their use is limited to a small group of tumors carrying specific oncogenic drivers. Among these, inhibitors targeting neurotrophic tyrosine receptor kinases (NTRK) are showing promising effects in reducing CNS metastases in cancers driven by gene rearrangements of these drugs\u2019 targets. However, wild-type NTRKs are susceptible to activation by their canonical ligands, which are expressed throughout the BM niche and can, in a paracrine manner, activate NTRK function in cancer cells. In this study, we show that NTRKs are expressed in primary tumors, BM, and lung cancer cells with various driver mutations expressing wild-type NTRK2 (WT-TrkB). We demonstrate that WT-TrkB activates downstream signaling and proliferation in response to exogenous brain-derived neurotrophic factor (BDNF) and conditioned media from reactive astrocytes known to secrete BDNF in the brain niche. Importantly, the FDA-approved NTRK inhibitor entrectinib blocked BDNF and astrocyte-induced survival pathways in multiple lung cancer cell lines, decreased their proliferation in vitro, and effectively prevented BM colonization and progression in vivo without significant effects on extracranial disease. Thus, these studies suggest that brain-dependent activation of NTRK is critical for BM of WT-NTRK+ lung cancers; therefore, NTRK inhibitors can be used to target nonfusion NTRK function to prevent or decrease BM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>These studies demonstrate that NTRK wild-type receptors are important drivers of brain metastatic colonization and progression in different subtypes of lung cancer, independent of their driver alterations. Thus, they provide a rationale to expand the use of FDA-approved NTRK inhibitors with brain penetrance for the prevention of CNS metastases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0811","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:59:04Z","timestamp":1784674744000},"page":"1850-1861","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting Wild-type\n                    <i>NTRK<\/i>\n                    in\n                    <i>NTRK<\/i>\n                    Fusion\u2013Negative Lung Cancer Decreases Brain Metastases"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0045-549X","authenticated-orcid":false,"given":"Maria J.","family":"Contreras-Z\u00e1rate","sequence":"first","affiliation":[{"name":"1Department of Pathology, University of Colorado Anschutz, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6416-0948","authenticated-orcid":false,"given":"Jenny A.","family":"Jaramillo-G\u00f3mez","sequence":"additional","affiliation":[{"name":"1Department of Pathology, University of Colorado Anschutz, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7188-6158","authenticated-orcid":false,"given":"R. Alejandro","family":"Marquez-Ortiz","sequence":"additional","affiliation":[{"name":"1Department of Pathology, University of Colorado Anschutz, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9305-2011","authenticated-orcid":false,"given":"Trinh C.","family":"Pham","sequence":"additional","affiliation":[{"name":"1Department of Pathology, University of Colorado Anschutz, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4165-8345","authenticated-orcid":false,"given":"Stella N.","family":"Koliavas","sequence":"additional","affiliation":[{"name":"1Department of Pathology, University of Colorado Anschutz, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7027-2915","authenticated-orcid":false,"given":"D. Ryan","family":"Ormond","sequence":"additional","affiliation":[{"name":"2Department of Neurosurgery, University of Colorado Anschutz, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7360-3369","authenticated-orcid":false,"given":"Andre C.","family":"Navarro","sequence":"additional","affiliation":[{"name":"3Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2369-2535","authenticated-orcid":false,"given":"Raphael A.","family":"Nemenoff","sequence":"additional","affiliation":[{"name":"3Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1280-175X","authenticated-orcid":false,"given":"D. Ross","family":"Camidge","sequence":"additional","affiliation":[{"name":"4Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8392-0800","authenticated-orcid":false,"given":"Diana M.","family":"Cittelly","sequence":"additional","affiliation":[{"name":"1Department of Pathology, University of Colorado Anschutz, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"2026080414415295500_bib1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nec.2020.06.001","article-title":"Epidemiology of brain metastases","volume":"31","author":"Sacks","year":"2020","journal-title":"Neurosurg Clin N Am"},{"key":"2026080414415295500_bib2","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann Oncol"},{"key":"2026080414415295500_bib3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1158\/2159-8290.CD-16-1237","article-title":"Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib: combined results from two phase I trials (ALKA-372-001 and STARTRK-1)","volume":"7","author":"Drilon","year":"2017","journal-title":"Cancer Discov"},{"key":"2026080414415295500_bib4","doi-asserted-by":"publisher","first-page":"103545","DOI":"10.1016\/j.jtho.2025.12.104","article-title":"Hiding in plain sight: the neuro-protective benefit of tropomyosin receptor kinase inhibition in non-neurotrophic receptor tyrosine kinase-driven lung cancers","volume":"21","author":"Camidge","year":"2026","journal-title":"J Thorac Oncol"},{"key":"2026080414415295500_bib5","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.jtho.2018.07.001","article-title":"The incidence of brain metastases in stage IV ROS1-rearranged non-small cell lung cancer and rate of central nervous system progression on crizotinib","volume":"13","author":"Patil","year":"2018","journal-title":"J Thorac Oncol"},{"key":"2026080414415295500_bib6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/s0301-0082(00)00014-9","article-title":"Brain-derived neurotrophic factor in the control human brain, and in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"63","author":"Murer","year":"2001","journal-title":"Prog Neurobiol"},{"key":"2026080414415295500_bib7","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1038\/s41388-019-0756-z","article-title":"Estradiol induces BDNF\/TrkB signaling in triple-negative breast cancer to promote brain metastases","volume":"38","author":"Contreras-Zarate","year":"2019","journal-title":"Oncogene"},{"key":"2026080414415295500_bib8","doi-asserted-by":"publisher","first-page":"10299","DOI":"10.1073\/pnas.1404399111","article-title":"Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis","volume":"111","author":"Sinkevicius","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026080414415295500_bib9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.lungcan.2012.07.011","article-title":"Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer","volume":"78","author":"Okamura","year":"2012","journal-title":"Lung Cancer"},{"key":"2026080414415295500_bib10","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/labinvest.2017.45","article-title":"Brain-derived neurotrophic factor\/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma","volume":"97","author":"Ozono","year":"2017","journal-title":"Lab Invest"},{"key":"2026080414415295500_bib11","doi-asserted-by":"publisher","first-page":"5962","DOI":"10.1158\/1078-0432.CCR-08-0651","article-title":"On Trk\u2013the TrkB signal transduction pathway is an increasingly important target in cancer biology","volume":"15","author":"Thiele","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2026080414415295500_bib12","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1158\/1078-0432.CCR-10-1890","article-title":"Brain-derived neurotrophic factor and neurotrophin-4\/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival","volume":"17","author":"Vanhecke","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2026080414415295500_bib13","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/cncr.25674","article-title":"The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan","volume":"117","author":"Zage","year":"2011","journal-title":"Cancer"},{"key":"2026080414415295500_bib14","doi-asserted-by":"publisher","first-page":"e100944","DOI":"10.1371\/journal.pone.0100944","article-title":"Cooperation of tyrosine kinase receptor TrkB and epidermal growth factor receptor signaling enhances migration and dispersal of lung tumor cells","volume":"9","author":"G\u00f6tz","year":"2014","journal-title":"PLoS One"},{"key":"2026080414415295500_bib15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13058-017-0844-3","article-title":"Cooperation of neurotrophin receptor TrkB and Her2 in breast cancer cells facilitates brain metastases","volume":"19","author":"Choy","year":"2017","journal-title":"Breast Cancer Res"},{"key":"2026080414415295500_bib16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn2038","article-title":"Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF","volume":"11","author":"Matsumoto","year":"2008","journal-title":"Nat Neurosci"},{"key":"2026080414415295500_bib17","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.1523\/JNEUROSCI.2535-21.2022","article-title":"Differential regulation of the BDNF gene in cortical and hippocampal neurons","volume":"42","author":"Esvald","year":"2022","journal-title":"J Neurosci"},{"key":"2026080414415295500_bib18","doi-asserted-by":"publisher","first-page":"14002","DOI":"10.1523\/JNEUROSCI.1592-15.2015","article-title":"Astrocytes promote oligodendrogenesis after white matter damage via brain-derived neurotrophic factor","volume":"35","author":"Miyamoto","year":"2015","journal-title":"J Neurosci"},{"key":"2026080414415295500_bib19","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1006\/nbdi.2000.0318","article-title":"Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia\/macrophages after spinal cord injury","volume":"7","author":"Dougherty","year":"2000","journal-title":"Neurobiol Dis"},{"key":"2026080414415295500_bib20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1017\/S1740925X09000052","article-title":"Glutamate elicits release of BDNF from basal forebrain astrocytes in a process dependent on metabotropic receptors and the PLC pathway","volume":"4","author":"Jean","year":"2008","journal-title":"Neuron Glia Biol"},{"key":"2026080414415295500_bib21","doi-asserted-by":"publisher","first-page":"8186","DOI":"10.1523\/JNEUROSCI.4267-13.2014","article-title":"Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination","volume":"34","author":"Fulmer","year":"2014","journal-title":"J Neurosci"},{"key":"2026080414415295500_bib22","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1200\/JCO.20.03025","article-title":"Updated integrated analysis of the efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small-cell lung cancer","volume":"39","author":"Dziadziuszko","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026080414415295500_bib23","doi-asserted-by":"publisher","first-page":"216062","DOI":"10.1016\/j.canlet.2023.216062","article-title":"Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response","volume":"556","author":"Kleczko","year":"2023","journal-title":"Cancer Lett"},{"key":"2026080414415295500_bib24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/bjc.1984.67","article-title":"Heterogeneity in a spontaneous mouse lung carcinoma: selection and characterisation of stable metastatic variants","volume":"49","author":"Layton","year":"1984","journal-title":"Br J Cancer"},{"key":"2026080414415295500_bib25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cell.2009.04.030","article-title":"WNT\/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis","volume":"138","author":"Nguyen","year":"2009","journal-title":"Cell"},{"key":"2026080414415295500_bib26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-61779-452-0_4","article-title":"Preparation of mixed glial cultures from postnatal rat brain","volume":"814","author":"de Vellis","year":"2012","journal-title":"Methods Mol Biol"},{"key":"2026080414415295500_bib27","doi-asserted-by":"publisher","first-page":"6209","DOI":"10.1158\/1078-0432.Ccr-21-0361","article-title":"IL13R\u03b12 promotes proliferation and outgrowth of breast cancer brain metastases","volume":"27","author":"M\u00e1rquez-Ortiz","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2026080414415295500_bib28","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2026080414415295500_bib29","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.1038\/s41467-022-33365-y","article-title":"The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"2026080414415295500_bib30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1128\/mcb.9.1.24-33.1989","article-title":"Molecular and biochemical characterization of the human trk proto-oncogene","volume":"9","author":"Martin-Zanca","year":"1989","journal-title":"Mol Cell Biol"},{"key":"2026080414415295500_bib31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","article-title":"Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse","volume":"89","author":"Zhang","year":"2016","journal-title":"Neuron"},{"key":"2026080414415295500_bib32","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Zhang","year":"2014","journal-title":"J Neurosci"},{"key":"2026080414415295500_bib33","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1038\/onc.2015.353","article-title":"Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism","volume":"35","author":"Sartorius","year":"2016","journal-title":"Oncogene"},{"key":"2026080414415295500_bib34","first-page":"4767","article-title":"Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase","volume":"60","author":"Marchetti","year":"2000","journal-title":"Cancer Res"},{"key":"2026080414415295500_bib35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10585-010-9354-8","article-title":"Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis","volume":"28","author":"Seike","year":"2011","journal-title":"Clin Exp Metastasis"},{"key":"2026080414415295500_bib36","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/biology11071063","article-title":"Is brain-derived neurotrophic factor a metabolic hormone in peripheral tissues?","volume":"11","author":"Iu","year":"2022","journal-title":"Biology (Basel)"},{"key":"2026080414415295500_bib37","doi-asserted-by":"publisher","first-page":"150431","DOI":"10.1016\/j.bbrc.2024.150431","article-title":"Reactive astrocytes promote tumor progression by up-regulating tumor protocadherin 1 expression in lung cancer brain metastasis","volume":"732","author":"Tang","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"2026080414415295500_bib38","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41556-023-01241-6","article-title":"Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasis","volume":"25","author":"Qu","year":"2023","journal-title":"Nat Cell Biol"},{"key":"2026080414415295500_bib39","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-023-06678-1","article-title":"Glioma synapses recruit mechanisms of adaptive plasticity","volume":"623","author":"Taylor","year":"2023","journal-title":"Nature"},{"key":"2026080414415295500_bib40","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-019-1576-6","article-title":"Synaptic proximity enables NMDAR signalling to promote brain metastasis","volume":"573","author":"Zeng","year":"2019","journal-title":"Nature"},{"key":"2026080414415295500_bib41","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/s41586-025-09492-z","article-title":"Neuronal activity-dependent mechanisms of small cell lung cancer pathogenesis","volume":"646","author":"Savchuk","year":"2025","journal-title":"Nature"},{"key":"2026080414415295500_bib42","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/s41586-025-09434-9","article-title":"Functional synapses between neurons and small cell lung cancer","volume":"646","author":"Sakthivelu","year":"2025","journal-title":"Nature"},{"key":"2026080414415295500_bib43","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1172\/JCI43992","article-title":"Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice","volume":"121","author":"Cazorla","year":"2011","journal-title":"J Clin Invest"},{"key":"2026080414415295500_bib44","doi-asserted-by":"publisher","first-page":"e9777","DOI":"10.1371\/journal.pone.0009777","article-title":"Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice","volume":"5","author":"Cazorla","year":"2010","journal-title":"PLoS One"},{"key":"2026080414415295500_bib45","doi-asserted-by":"publisher","first-page":"8135","DOI":"10.1038\/s41598-018-26408-2","article-title":"The neurotrophic tyrosine kinase receptor TrkA and its ligand NGF are increased in squamous cell carcinomas of the lung","volume":"8","author":"Gao","year":"2018","journal-title":"Sci Rep"},{"key":"2026080414415295500_bib46","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1158\/0008-5472.CAN-24-0658","article-title":"Targeting NTRK1 enhances immune checkpoint inhibitor efficacy in NTRK1 wild-type non-small cell lung cancer","volume":"84","author":"Smith","year":"2024","journal-title":"Cancer Res"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0811\/3814612\/crc-25-0811.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/8\/1850\/3818905\/crc-25-0811.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/8\/1850\/3818905\/crc-25-0811.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:42:02Z","timestamp":1785868922000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/8\/1850\/787258\/Targeting-Wild-type-NTRK-in-NTRK-Fusion-Negative"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0811","relation":{},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}